Skip Navigation

skip navigationNIDDK Home
NIDDK Reference Collection
Diet   Exercise   Health  
Home Page
-  

FAQ

Detailed Search

- -
NIDDK INFORMATION SERVICES
- -

Diabetes

Digestive Diseases

Endocrine and Metabolic Diseases

Hematologic Diseases

Kidney and Urologic Diseases

Weight-control Information Network

-
NIDDK EDUCATION
PROGRAMS

- -

National Diabetes Education Program

National Kidney Disease Education Program

-
- - -
NIDDK Home
-
Contact Us
-
New Search
-

Link to this page

Your search term(s) "hypoglycemia" returned 234 results.

Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24    Display All


Management of Competitive Athletes with Diabetes. Diabetes Spectrum. 18(2): 102-107. Spring 2005.

This article describes an effective management plan for an athlete with type 1 diabetes. Such a plan must consider the energy demands of intense competition and training, the athlete's goals, factors related to competitive sports that may affect glucose homeostasis, and strategies that may be employed to allow safe, effective sports participation. One section addresses how to minimize risky behaviors, including omission of insulin for weight loss. The authors focus on nutrition, diet therapy and energy needs. They caution that the most common acute risks for competitive athletes with diabetes are exercise-induced hypoglycemia and deterioration of hyperglycemia and ketosis brought on by physical activity during periods of hypoinsulinemia. The authors conclude that athletes should be appropriately screened, counseled to avoid risky behaviors, and provided with specific recommendations for glucose monitoring and insulin and diet adjustments so that they may anticipate and compensate for glucose responses during sports competition. 1 figure. 38 references.

Full Record   Printer Friendly Version


 

Managing Prediabetes: Self-Care Handbook. South Deerfield, MA: Channing Bete Company. 2005. 31 p.

This booklet is designed to educate people who have been diagnosed with pre-diabetes, a condition in which the blood glucose levels are elevated, but not to such an extent that a diagnosis of diabetes is warranted. The booklet covers the dangers of prediabetes, the risk factors for diabetes, diagnostic tests and monitoring strategies that may be used, lifestyle changes, setting goals, determining a healthy weight, weight loss tips, nutrition basics, meal planning, the role of exercise, keeping records of food and activities, dealing with stress, and family considerations. The booklet is filled with charts and illustrations, places to record individualized information, and black-and-white photographs of a variety of people undertaking a variety of activities. A tear-out card is included that readers can bring with them to their health care appointments; the card includes room to record blood glucose test results and special instructions. The booklet concludes with a list of the answers to common questions about prediabetes, as well as a list of resource organizations through which readers can get more information. 5 figures. 5 tables.

Full Record   Printer Friendly Version


 

Maternal and Fetal Complications Associated with Gestational Diabetes Mellitus. IN: Thomas, A.M.; Gutierrez, Y.M., eds. American Dietetic Association Guide to Gestational Diabetes Mellitus. Chicago, IL: American Dietetic Association. 2005. pp. 27-34.

This chapter on the maternal and fetal complications associated with gestational diabetes mellitus (GDM) is from a Guide that serves as a resource for health professionals involved in the care of women who develop diabetes during their pregnancy. The Guide helps readers to promote sound nutrition principles in GDM, to achieve optimal outcomes for the woman and her infant. The authors of this chapter begins by describing the maternal complications of GDM: hypertension, polyhydramnios, difficult birth, preterm delivery, and Cesarean section. The chapter then goes on to address the fetal complications, including macrosomia, neonatal hypoglycemia, respiratory distress syndrome, neonatal hypocalcemia, neonatal hyperbilirubinemia, polycythemia, and congenital anomalies. The authors conclude that if maternal euglycemia is obtained and maintained at optimal levels during pregnancy through medical nutrition therapy (MNT) and other necessary interventions, the risk of complications will be minimized and the maternal and fetal outcomes are improved. 54 references.

Full Record   Printer Friendly Version


 

Medical Identification. Diabetes Self-Management. 22(2): 55-57. March-April 2005.

This article provides information about the use of medical identification tags for people who have diabetes. Identification tags can provide awareness of the existence of diabetes; this can assist in diagnosis, medication choice and possibly prevent hypoglycemia from becoming severe. The author describes the different levels of hypoglycemia and their symptoms, and the different types of identification jewelry available. The article concludes with a list of manufacturers with their contact information and a brief description of their products.

Full Record   Printer Friendly Version


 

Medications and Supplements. IN: Thomas, A.M.; Gutierrez, Y.M., eds. American Dietetic Association Guide to Gestational Diabetes Mellitus. Chicago, IL: American Dietetic Association. 2005. pp. 65-80.

This chapter on medications and supplements in gestational diabetes mellitus (GDM) is from a Guide that serves as a resource for health professionals involved in the care of women who develop diabetes during their pregnancy. The Guide helps readers to promote sound nutrition principles in GDM, to achieve optimal outcomes for the woman and her infant. The author of this chapter begins by summarizing the types, action, peak times, and duration of insulin used in pregnancy. Other topics covered include the treatment modalities used for hypoglycemia, the use of oral agents used to treat diabetes in pregnancy, the use of multivitamin-mineral supplements in pregnancy, and the benefits and adverse effects of herbal and botanical supplements on pregnancy outcome. The author concludes that the goal in the management of GDM is normoglycemia. The first course of treatment is medical nutrition therapy (MNT); if blood glucose levels cannot be maintained by MNT, insulin must be initiated. The author emphasizes that nutrition assessment and counseling are recommended for all pregnant women. 6 figures. 4 tables. 64 references.

Full Record   Printer Friendly Version


 

New Medications for Diabetes Management. Today's Dietitian. 7(7): 20-22. July 2005.

This article describes some of the new medications used for diabetes management. As the understanding of diabetes increases, it becomes apparent that there is more to diabetes management than a simple balance of blood glucose and insulin. The broadened scope views diabetes as a disease that involves the whole gastrointestinal tract and other hormones in addition to insulin. This view may help to explain those patients who, despite their best efforts and the efforts of their medical team, cannot achieve their glycemic goals. The author describes two new medications, both of which are injectable: exenatide (an incretin mimetic) and pramlintide (an amylinomimetic). Both medications slow gastric emptying time, so certain other medications may also be affected by this reaction. Adequate adjustments to medications and insulin are needed to prevent hypoglycemia, especially with pramlintide. Exenatide is approved for use in people with type 2 diabetes who are currently using oral hypoglycemic agents (namely sulfonylureas and metformin) and who are poorly managed on their present protocol. Pramlintide is designed for use in patients with type 1 diabetes or type 2 diabetes who use insulin and who have not reached optimal results from insulin therapy. Pramlintide cannot be mixed with insulin, however, and must be injected separately, prior to meals. References for this article are available online (email to TDeditor@gvpub.com).

Full Record   Printer Friendly Version


 

Overcoming Barriers to Intensive Insulin Administration. Reducing Cardiovascular Risk in the Patient with Type 2 Diabetes (AADE Proceedings). p. 7-8. 2005.

This article, from the proceedings of a symposium on reducing cardiovascular risk in people with type 2 diabetes, considers strategies to overcome barriers to intensive insulin administration. The author argues that in order to reach and maintain blood glucose target levels, clinicians must implement more intensive treatment regimens than the traditional stepwise approach that begins with lifestyle modifications, then hypoglycemia agents, then adds insulin. However, the earlier use of exogenous insulin preserves and improves beta cell function, helps to restore normal insulin sensitivity, and improves the effectiveness of oral medications. Some of the barriers to insulin therapy include patient reluctance, concerns about lifestyle changes and restrictions, social embarrassment, painful injections, and the association of insulin with worsening health. Physicians and patients both worry about weight gain and hypoglycemia associated with insulin use. Many primary care providers lack the experience and support they need (access to other diabetes health care providers, for example) to successfully manage insulin regimens. The author focuses on the implementation of simple insulin regimens as a vital part of the care of patients with type 2 diabetes. 7 references.

Full Record   Printer Friendly Version


 

Physical Activity: The Magic of Movement. Diabetes Self-Management. 22(1): 7-12. January-February 2005.

This article explores the benefits of physical activity for people with diabetes. These benefits can include lower blood glucose readings, reduced stress, and decreased body fat. The authors explain how exercise can lower blood glucose by both burning glucose and by improving the body's ability to use insulin. This improvement in insulin sensitivity may even allow some people with Type 2 diabetes to reduce or discontinue blood-glucose-lowering medications. The cardiovascular benefits are also particularly important in a patient population at high risk for cardiovascular complications. Other topics covered include steps to take before undergoing an exercise program, how diabetes complications can affect one's choice of physical activities, the significant health benefits that can be obtained by a moderate amount of physical activity, the importance of warm-up and cool-down periods, foot care, use of medical identification tags, the need to have a carbohydrate source available during and after exercise, and hypoglycemia concerns. The authors conclude by recommending that patients make a commitment to physical activity and work with their doctor to plan a individualized exercise prescription.

Full Record   Printer Friendly Version


 

Pramlintide Use in Type 1 Diabetes Resulting in Less Hypoglycemia. Diabetes Spectrum. 19(1): 50-52. Winter 2005.

This article presents a case report of a 49 year old white male who has had type 1 diabetes for 43 years, and been on an intensive insulin regimen since 1982. The author describes the inclusion of pramlintide to help this patient reduce his incidence of hypoglycemia, which had intensified over the years and even resulted in an automobile accident in 2003. The author presents the case report and then lists the questions that the health care provider must consider. The discussion section offers strategies to improve this patient's care and diabetes control. Pramlintide is an analog of the naturally occurring pancreatic hormone amylin, which works with insulin to suppress glucagon secretion and to regulate gastric emptying. The case report patient had widely fluctuating blood glucose levels, frequent hypoglycemia, persistent postprandial hyperglycemia, and weight gain, despite intensive insulin regimens and skillful diabetes self-management. The author reports on the case patient's management during 18 months on pramlintide (in addition to his regular insulin regimen); since starting pramlintide, the patient's HbA1c has improved, his weight is stable, and he has had less hypoglycemia and less fluctuation in his blood glucose levels. Patient care strategies, including administration and dosing suggestions, are provided. 3 tables. 5 references.

Full Record   Printer Friendly Version


 

Problem-Solving School Issues. Diabetes Self-Management. 22(6): 26-31. November-December 2005.

When planning for academic success and physical health in school, the parents of children with diabetes must address both practical and psychological considerations. This article offers advice to parents for problem-solving school issues. Topics include the importance of having a plan in place before school starts, meeting with school personnel, recordkeeping, understanding the child's rights as protected by legislation, and handling emotional issues. A final section answers frequently asked questions, including the topics of snack foods at school, insulin administration and dosage, overtreatment of hypoglycemia, and helping a child evolve to self-care over time. The author emphasizes the importance of good communication between parent and child as well as between the family and school personnel. One sidebar lists the signs of depression in children and adolescents; another provides a list of recommended resources on dealing with school issues. 7 references.

Full Record   Printer Friendly Version


 

Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24    Display All

Start a new search.


View NIDDK Publications | NIDDK Health Information | Contact Us

The NIDDK Reference Collection is a service of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.
NIDDK Clearinghouses Publications Catalog
5 Information Way
Bethesda, MD 20892–3568
Phone: 1–800–860–8747
TTY: 1–866–569–1162
Fax: 703–738–4929
Email: catalog@niddk.nih.gov

Privacy | Disclaimers | Accessibility | Public Use of Materials
H H S logo - link to U. S. Department of Health and Human Services NIH logo - link to the National Institute of Health NIDDK logo - link to the National Institute of Diabetes and Digestive and Kidney Diseases